Advanced Health Intelligence (AHI) is on a mission to support proactive, personalized healthcare for every smartphone user globally.
The company is a leader in providing innovative health technology solutions for proactive risk management. With AHI’s smartphone-based platform, individuals can complete a comprehensive health assessment from the comfort and privacy of their own homes.
AHI’s biometric health assessments offer enhanced risk stratification and automated digital triage for scalable access and convenience at populations scale.
Advanced Health Intelligence is one of the many featured companies slated to present at The Microcap Conference 2024, set for Jan. 30-Feb. 1 at Caesars Atlantic City Hotel and Casino. This three-day conference presented by DealFlow Events features technical programming designed for microcap investors and a presenting company track for pitching and socializing.
The company’s stock is listed on the ASX and Nasdaq under the ticker symbol AHI.
AHI’s Biometric Health Assessment (BHA) is an innovative process that leverages multiple smartphone sensors to conduct non-invasive BodyScans, FaceScans and Finger PPGs, then harnesses proprietary algorithms and the processing power of a smartphone to evaluate risks. This comprehensive assessment produces a report to the user immediately, covering 61 outputs across five major health categories. The BHA is completed in less than 15 minutes and involves four key steps:
- FaceScan: The process begins with facial scans to determine the probability of an individual’s blood pressure risk zones. Alongside this, the BHA gathers data like demographic information, daily activity intensity, chronic medication usage, and smoking status.
- Photoplethysmogram (PPG) Resting Heart Rate Measurement: In this stage, the user’s resting heart rate is captured while in a guided posture, helping further evaluate the baseline heart health.
- BodyScan Body Composition Analysis: The smartphone conducts a body scan during this phase, producing waist and hip circumference and body fat percentage.
- Cardiovascular Fitness Evaluation: This phase involves an exertion test, then monitoring heart rate recovery. It helps in assessing cardiovascular fitness levels.
Scientifically validated algorithmic assets from AHI leverage smartphone sensor data from the BHA, to calculate a range of additional measures related to human mortality and morbidity risk including digital blood lipid biomarkers (Cholesterol and triglycerides), inflammation markers, cardiorespiratory fitness and HbA1C.
Addressing a global health care priority
The rising costs of healthcare have become a global challenge and a major reality for both developed and developing countries. According to the World Health Organization (WHO), the global healthcare expenditure is projected to reach 10% of the Gross Domestic Product (GDP) by the year 2040.
By streamlining health assessment and triage into a smartphone experience, AHI offers pathways into improving population health literacy and empowering individuals to take better control of their health.
AHI aims to revolutionize healthcare with proprietary technology. This scalable technology allows the convenient and cost-effective distribution of health assessments to derive real-time risk stratification and automate digital triage at population-scale with improved accuracy.
The company’s comprehensive suite of digital health solutions creates a cohesive ecosystem that supports healthcare success.
CEO and Director Scott Montgomery has over 20 years of industry expertise bringing two of his B2B health companies to exit by leading teams to deploy enterprise health solutions to companies all around the world.
Founder and Head of Strategy Vlado Bosanac has spent over 30 years in several executive-level roles as a founder, investor, entrepreneur, philanthropist, technologist, advisor, and business consultant. He founded AHI 10 years ago.
Looking to the future
The company’s vision is nothing less than ubiquitous proactive healthcare for all. With the ubiquity and convenience of smartphones, AHI’s vision is to deliver a comprehensive and accessible suite of assessment tools to a broad spectrum of users, including healthcare providers, caregivers, insurers, and governments around the world.
Its mission is to improve healthcare outcomes, enhance health literacy, and support the early detection and management of various health conditions including obesity, diabetes, cardiovascular, stroke and heart attack risk, all on the smartphone. AHI’s vision extends beyond individual health assessments; it aspires to create a transformative impact at scale, driving forward a new era in digital healthcare that reaches populations globally.
AHI plans to continue leveraging its technology in a compliant, secure and cost-effective way.
Tickets to the inaugural Microcap Conference 2024 are going fast. Reserve your seat now for three days of unsurpassed networking and technical discussions of the microcap sector with some of the best names in the business – institutional investors, finance-focused law firms, venture and private equity fund managers, deal advisors, PIPE funds, brokerage firms, investor relations professionals, accredited retail investors and many more. The conference schedule is also packed with entertainment and exciting activities set against the backdrop of Atlantic City’s bright lights.
Sponsored content, this is a paid promotion
Comments and opinions presented in DealFlow Events publications such as The Microcap Newsletter are solely those of the analysts, corporate executives, and others quoted. They do not represent the opinions of DealFlow Events and DealFlow Events makes no recommendations on whether to buy, sell or hold shares of any particular stock. Investors are advised to conduct their own research before making an investment decision. Neither DealFlow Events nor any of its affiliates hold any position in the stocks mentioned in The Microcap Newsletter.